- Home
- A-Z Publications
- Current Nanomedicine
- Fast Track Listing
Current Nanomedicine - Online First
Description text for Online First listing goes here...
-
-
The Nano-Neuro Tempo: An Opinion
Available online: 02 October 2024More LessThe unveiled properties of a wide variety of engineered nano assembly materials, such as nanostructures and quantum dots groups in cell biology and physiology, reveal desired interactivity at a fundamental molecular level. The vast progress in therapeutic strategies developed for nanoscale measurement and manipulation, which have functional nanostructures for sensing and modulating, entails specific interactions with neurons and glial cells without the need for genetic modification. The current tempo trend for the advancement of technologies is promising and fast- forward. The present opinion seeks to map the function of nano-enabled neural interfaces that have proven their potential in technological advancements in electronics and energy harvesting to biomedicine.
-
-
-
Recent Progress in Nanoemulsion Technology for the Management of Hepatic Diseases
Authors: Soniya Sarthi, Harish Bhardwaj and Rajendra Kumar JangdeAvailable online: 25 September 2024More LessLiver diseases pose a significant global health concern, particularly prevalent in developing nations, often induced by chemical exposure and high drug doses. Hepatic toxicity not only affects liver function but also extends to adjacent tissues, leading to diminished overall body function and necessitating effective treatment strategies. Despite modern medical advancements, stimulating liver function, protecting against damage, and promoting cell regeneration remain challenging tasks. Novel Drug Delivery Systems (NDDS), notably nanoemulsions, present promising avenues for addressing hepatic disorders. Nanoemulsions, characterized by biphasic dispersions of immiscible liquids stabilized by surfactants, possess unique drug-loading capabilities and viscoelastic properties that render them ideal candidates for liver-related conditions. However, their development, manufacturing, and manipulation for hepatic disorders are constrained by the partial applicability of conventional emulsion principles. This comprehensive review delves into various aspects of liver function, disease types, nanoemulsions, associated limitations and challenges, ongoing clinical trials, patents, and their inherent advantages. By shedding light on recent advancements in Nanoemulsion for hepatoprotective activity management, the review aims to illuminate the potential of tailored drug delivery systems in revolutionizing hepatic disease management. Exploring Nanoemulsion for hepatoprotective activity management signifies a crucial step toward offering targeted and efficient treatment modalities for liver diseases. Harnessing the unique capabilities of nanoemulsions could lead to significant improvements in patient outcomes and quality of life, thereby addressing the pressing global health concern posed by hepatic disorders.
-